1. Home
  2. NVNO vs JLS Comparison

NVNO vs JLS Comparison

Compare NVNO & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • JLS
  • Stock Information
  • Founded
  • NVNO 1987
  • JLS 2009
  • Country
  • NVNO United States
  • JLS United States
  • Employees
  • NVNO N/A
  • JLS N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • JLS Investment Managers
  • Sector
  • NVNO Health Care
  • JLS Finance
  • Exchange
  • NVNO Nasdaq
  • JLS Nasdaq
  • Market Cap
  • NVNO 96.0M
  • JLS 103.4M
  • IPO Year
  • NVNO N/A
  • JLS N/A
  • Fundamental
  • Price
  • NVNO $4.91
  • JLS $18.78
  • Analyst Decision
  • NVNO
  • JLS
  • Analyst Count
  • NVNO 0
  • JLS 0
  • Target Price
  • NVNO N/A
  • JLS N/A
  • AVG Volume (30 Days)
  • NVNO 136.6K
  • JLS 26.6K
  • Earning Date
  • NVNO 07-31-2025
  • JLS 01-01-0001
  • Dividend Yield
  • NVNO N/A
  • JLS 9.33%
  • EPS Growth
  • NVNO N/A
  • JLS N/A
  • EPS
  • NVNO N/A
  • JLS N/A
  • Revenue
  • NVNO N/A
  • JLS N/A
  • Revenue This Year
  • NVNO N/A
  • JLS N/A
  • Revenue Next Year
  • NVNO N/A
  • JLS N/A
  • P/E Ratio
  • NVNO N/A
  • JLS N/A
  • Revenue Growth
  • NVNO N/A
  • JLS N/A
  • 52 Week Low
  • NVNO $2.03
  • JLS $15.48
  • 52 Week High
  • NVNO $5.70
  • JLS $17.97
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 56.87
  • JLS 45.16
  • Support Level
  • NVNO $4.33
  • JLS $18.87
  • Resistance Level
  • NVNO $5.13
  • JLS $19.00
  • Average True Range (ATR)
  • NVNO 0.35
  • JLS 0.12
  • MACD
  • NVNO -0.05
  • JLS -0.02
  • Stochastic Oscillator
  • NVNO 62.50
  • JLS 7.69

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

Share on Social Networks: